Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information... Show more
FLGT is expected to report earnings to fall 510.50% to -16 cents per share on August 01
Q2'25
Est.
$-0.16
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.43
Q3'24
Beat
by $0.46
Q2'24
Beat
by $0.45
The last earnings report on May 02 showed earnings per share of 3 cents, beating the estimate of -7 cents. With 54.08K shares outstanding, the current market capitalization sits at 648.84M.